Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#2032 Current Educational Strategies Used by Nurses Caring for NET Patients: Electronic Survey across 25 Countries

Introduction: The ENETS Nurse Group performed a short pilot survey in 2015 to locate nurses who take care of NET patients and to explore NET nurse education needs. The results of this survey were used to design a more detailed electronic survey.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Davies P

Authors: Davies P, Falkerby J, Geilvoet W, Fernandez Ortega M, Munk Plum L,

Keywords: Nurse, Education, Neuroendocrine Tumor,

#1847 CXCR4 Inhibition by Ulocuplumab Prevents EMT of pNET Cells in Vitro

Introduction: Neuroendocrine tumors (NETs) overexpress CXCR4. We have previously shown that stimulation of CXCR4 by its ligand SDF-1 promotes the epithelial-mesenchymal transition (EMT) and increases distant tumor spread. Ulocuplumab (Ulo) is a fully human IgG4 mAb designed to inhibit the binding of CXCR4 to SDF-1.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Quaresmini D

Authors: Quaresmini D, Cives M, Pellè E, Ungaro A, Felici C,

Keywords: pNET, CXCR4, EMT, Ulocuplumab,

#481 Quality of Life in Patients with Neuroendocrine Tumors: A Cross-Sectional Study

Introduction: Living with cancer affects not only physical and mental health but also the social and professional life of the patient. Measuring quality of life (Qol) is one way to learn from the patient perspective.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Plum L, Knigge U,

Keywords: quality of life,

#452 Clinical and Psychometric Validation of the Disease-Specific Questionnaire Module (EORTC QLQ-GINET21) in Assessing Quality of Life of Patients with Neuroendocrine Tumors

Introduction: Quality of life (QoL) is an important outcome measure in clinical trials and is increasingly being used as an endpoint. The QLQ-GINET21 is a questionnaire developed with the EORTC QoL Group but which had not previously been validated.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Ramage J, Yadegarfar G, Friend L, Jones L, Plum L,

Keywords: Quality of Life, PROMS,